Skip to main content
Premium Trial:

Request an Annual Quote

Biogazelle mRNA Sequencing

Biogazelle has launched its mRNA sequencing service for human plasma and other bodily fluids. The company uses massively parallel sequencing to quantify and characterize mRNA molecules in low volumes of plasma and can detect between 6,000 and 8,000 genes, it said. This type of analysis provides an order of magnitude more biomarkers than microRNA sequencing, and since it is a liquid biopsy-based technology it allows for serial follow-up of patients to monitor them for disease, the company added.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.